Related Experiment Video
Updated: Dec 23, 2025

Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
[Medication and comedication in COVID-19 patients]
M Lenkens1, H de Wit2, A H Danser3
1CWZ, afd. Interne Geneeskunde, Nijmegen.
Comedication likely does not worsen COVID-19 outcomes, but NSAIDs should be avoided in severe cases. Current treatments like chloroquine and remdesivir lack strong evidence, making supportive care essential.
Area of Science:
- Infectious Diseases
- Pharmacology
- Internal Medicine
Background:
- COVID-19 presents complex treatment challenges.
- The role of comedication in COVID-19 progression is unclear.
- Existing treatment options require further validation.
Purpose of the Study:
- To evaluate the impact of comedication on COVID-19.
- To review current and potential therapeutic strategies for COVID-19.
- To provide guidance on managing patients with comorbidities.
Main Methods:
- Literature review of studies on COVID-19 treatments.
- Analysis of potential drug interactions and side effects.
- Assessment of evidence for chloroquine, remdesivir, and other agents.
Main Results:
- Comedication is unlikely to adversely affect COVID-19 course.
- Non-steroidal anti-inflammatory drugs (NSAIDs) should be used cautiously.
- Renin-angiotensin aldosterone system inhibitors can be continued if indicated.
- Chloroquine and remdesivir show limited evidence and potential side effects.
- Lopinavir/ritonavir demonstrated ineffectiveness.
- Supportive care remains the primary treatment modality.
Conclusions:
- Careful consideration of comedications is necessary for COVID-19 patients.
- Evidence for specific antiviral treatments is currently insufficient.
- Management should prioritize supportive care and individualized treatment plans.
More Related Videos
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Inhaled Medications
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Drug Therapy
Antianxiety Medications
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...